Celator® Pharmaceuticals Raises $20 Million in Series D Financing
Celator Pharmaceuticals, a privately held pharmaceutical company developing new and more effective therapies to treat cancer based on the company's proprietary technology, today announced that it raised $20 million in a Series D private equity financing. Â Proceeds will support completion of ongoing clinical trials and activities related to advancing the company's lead investigational product ...
Read more on PR Newswire via Yahoo! Finance